Sugi Predict

Sugi Predict / Targets / STARD7

STARD7

StAR-related lipid transfer protein 7, mitochondrial · Q9NQZ5 · STARD7 on Sugi Atlas →

171 patent compounds predicted against STARD7, 154 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1233503 SCHEMBL1233503 1.00 1/20
SCHEMBL1233504 SCHEMBL1233504 1.00 1/20
SCHEMBL13470343 SCHEMBL13470343 0.85 1/20
SCHEMBL1235844 SCHEMBL1235844 0.82 1/20
SCHEMBL1235205 SCHEMBL1235205 0.81 1/20
SCHEMBL1233511 SCHEMBL1233511 0.79 1/20
SCHEMBL1234605 SCHEMBL1234605 0.79 1/20
SCHEMBL1234435 SCHEMBL1234435 0.79 1/20
SCHEMBL1235093 SCHEMBL1235093 0.79 1/20
SCHEMBL1234494 SCHEMBL1234494 0.78 1/20
SCHEMBL17066575 SCHEMBL17066575 0.77 1/20
SCHEMBL13275764 SCHEMBL13275764 0.77 1/20
SCHEMBL1234489 SCHEMBL1234489 0.76 1/20
SCHEMBL1234613 SCHEMBL1234613 0.76 1/20
SCHEMBL1235845 SCHEMBL1235845 0.74 1/20
SCHEMBL1234444 SCHEMBL1234444 0.73 1/20
SCHEMBL1235180 SCHEMBL1235180 0.73 1/20
SCHEMBL1235095 SCHEMBL1235095 0.73 1/20
SCHEMBL4554977 SCHEMBL4554977 0.72 1/20
SCHEMBL1234495 SCHEMBL1234495 0.72 1/20

Clinical trials — most relevant to STARD7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy PHASE3COMPLETED
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy PHASE3RECRUITING
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC PHASE1/PHASE2UNKNOWN
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Choline Effects - Pre-symptomatic AD PHASE1COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH nanCOMPLETED
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
PGC-1 and Mitochondrial Dysfunction in Diabetes nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 nanCOMPLETED
Diabetic Cardiomyopathy and Heart Failure nanWITHDRAWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
Epidemiology of Atherosclerosis nanCOMPLETED
The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales nanRECRUITING
Diagnostic Odyssey Survey 2 nanCOMPLETED
Mitochondrial Dysfunction in Diabetes nanCOMPLETED
A Study to Improve Skeletal Muscle in Veterans With HIV nanRECRUITING
Combined Effects of Statins and Exercise on Training Sensitive Health Markers nanCOMPLETED
Impact Of Choline in Patients With NAFLD nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a STARD7 binder may also engage these)

ProteinNameSimilarity
Q8R1R3 — 1.000 Q8R1R3 →
Q496Y0 — 0.967 Q496Y0 →
Q8BHD4 — 0.965 Q8BHD4 →
Q9BXB4 — 0.963 Q9BXB4 →
Q5U2X1 — 0.962 Q5U2X1 →
ABHD16A Phosphatidylserine lipase ABHD16A 0.962 landscape →
Q5R803 — 0.962 Q5R803 →
Q641K1 — 0.961 Q641K1 →
Q8VEF1 — 0.961 Q8VEF1 →
GRAMD1A Protein Aster-A 0.961 landscape →
Q9BZF2 — 0.961 Q9BZF2 →
Q8CI95 — 0.960 Q8CI95 →
Q9UK97 — 0.960 Q9UK97 →
Q9ESL4 — 0.960 Q9ESL4 →
Q6ZT62 — 0.960 Q6ZT62 →
Q8NFZ0 — 0.959 Q8NFZ0 →
Q7TPQ3 — 0.959 Q7TPQ3 →
MAP3K15 Mitogen-activated protein kinase kinase kinase 15 0.959 landscape →
Q8HXH0 — 0.959 Q8HXH0 →
Q1JPD2 — 0.958 Q1JPD2 →
P97826 — 0.958 P97826 →
HLCS Biotin--protein ligase 0.958 landscape →
Q8BWW9 — 0.958 Q8BWW9 →
Q9UPW5 — 0.958 Q9UPW5 →
Q9NVU0 — 0.958 Q9NVU0 →
Q5T7W7 — 0.958 Q5T7W7 →
Q9D4H7 — 0.957 Q9D4H7 →
Q8N6S4 — 0.957 Q8N6S4 →
Q9ER64 — 0.957 Q9ER64 →
Q9BXB5 — 0.957 Q9BXB5 →